Anzeige
Mehr »
Dienstag, 14.10.2025 - Börsentäglich über 12.000 News
Der Mann, der ein Lithium-Unternehmen im Wert von 1,2 Milliarden Dollar aufgebaut hat, ist zurück...
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
06.10.Jazz and Roche's Zepzelca-Tecentriq wins FDA ES-SCLC approval
06.10.McMaster University and MIT discover new antibiotic for IBD
03.10.FDA approves mifepristone generic as political abortion war rages on
03.10.Takeda walks away from cell therapy in priority U-turn
03.10.Amgen's Phase III data supports FDA label expansion of Repatha
02.10.FDA winds down operations amid government shutdown
02.10.FDA leaders are "acting political", says ex-agency chief counsel
02.10.Halozyme eyes microparticles in $900m Elektrofi acquisition
02.10.AbbVie breaks ground on $70m US biologics site amid Trump pressure
01.10.US Government shuts down over funding impasse
01.10.Pfizer shakes hands with White House on drug discounts under MFN programme
01.10.Klotho to acquire Turn Biotechnologies' assets
01.10.Star Therapeutics gains $125m Series D funds to develop pipeline
01.10.Disruption due for long-held assumptions in biopharma, says BIA chair
30.09.Genmab to acquire Merus shares for $8bn
30.09.J&J gets FDA approval for Tremfya in paediatric psoriasis
30.09.NMPA approves Eisai and Biogen for Leqembi IV maintenance dosing
29.09.Amgen to invest $650m in US manufacturing network expansion
29.09.Regeneron's Evkeeza gains FDA approval for young HoFH patients
26.09.AstraZeneca launches DTC platform amid US pricing pressures
26.09.Drugmakers point to US expansion plans amid Trump's 100% drug tariff
26.09.FDA approves Lilly's Inluriyo to treat advanced breast cancer
26.09.European PE company prioritising CGT and other novel modality investments
26.09.Harmony's cannabidiol drug flops in pivotal Fragile X Syndrome trial
26.09.Synaffix and Qurient enter licensing deal for dual-payload ADC